Tempus gets U.S. FDA clearance for updated Tempus Pixel Device

2 hours ago 1

Tempus AI (NASDAQ:TEM) said that it has received clearance from the U.S. FDA for its updated Tempus Pixel, an AI-powered cardiac imaging platform.
This update allows the generation of T1 and T2 inline maps, helping the device’s capabilities for cardiac MR